TNF Pharmaceuticals, Inc. (TNFA)
NASDAQ: TNFA · Real-Time Price · USD
0.1819
+0.0032 (1.79%)
May 14, 2025, 9:43 AM - Market open

TNF Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
231345228-
Upgrade
Market Cap Growth
-75.94%-75.94%-70.99%-80.11%--
Upgrade
Enterprise Value
-7-7639213-
Upgrade
Last Close Price
0.181.157.7634.50181.80-
Upgrade
Debt / Equity Ratio
0.000.000.000.010.01-0.79
Upgrade
Quick Ratio
1.271.270.991.7511.120.06
Upgrade
Current Ratio
1.401.401.171.9512.180.06
Upgrade
Return on Equity (ROE)
-169.93%-169.93%-29.12%-79.27%-325.06%-
Upgrade
Return on Assets (ROA)
-27.56%-27.56%-57.77%-45.11%-138.30%-1227.92%
Upgrade
Return on Capital (ROIC)
-39.29%-39.29%-73.94%-49.45%-155.49%-
Upgrade
Buyback Yield / Dilution
-57.99%-57.99%-19.18%-10.88%-24.22%25.94%
Upgrade
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q